Novavax Inc (NASDAQ:NVAX)

41.58
BATS BZX Real-Time Price
As of 2:41pm ET
 +1.30 / +3.23%
Today’s Change
34.88
Today|||52-Week Range
277.80
-70.94%
Year-to-Date
3 Companies Growing Revenue Fast
1:23pm / GuruFocus News - Paid Partner Content
Novavax (NVAX) Q2 Earnings Miss, Cuts '22 Sales Guidance by Half
Aug 09 / Zacks.com - Paid Partner Content
1 Reason to Sell Novavax Stock, and 1 Reason to Buy
1:15pm / MotleyFool.com - Paid Partner Content
Reata (RETA) Q2 Earnings Miss, Revenues Down Y/Y, Stock Down
Aug 09 / Zacks.com - Paid Partner Content
Bausch (BHC) Q2 Earnings & Sales Miss, View Cut, Stock Down
11:56am / Zacks.com - Paid Partner Content
Apellis (APLS) Q2 Earnings and Sales Miss Estimates, Stock Down
Aug 09 / Zacks.com - Paid Partner Content
Stock Market News for Aug 10, 2022
9:31am / Zacks.com - Paid Partner Content
Why Novavax Stock Is Plunging Today
Aug 09 / MotleyFool.com - Paid Partner Content
Nasdaq Bear Market: 3 Remarkable Growth Stocks That Can Double Your Money by 2026
5:21am / MotleyFool.com - Paid Partner Content
Novavax Stock Is Crashing: These 3 Words Explain Why
Aug 09 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close40.28
Today’s open40.04
Day’s range38.50 - 41.61
Volume172,238
Average volume (3 months)6,792,076
Market cap$4.6B
Data as of 2:41pm ET, 08/10/2022

Growth & Valuation

Earnings growth (last year)-222.51%
Earnings growth (this year)+203.61%
Earnings growth (next 5 years)+36.40%
Revenue growth (last year)+141.02%
P/E ratioNM
Price/Sales9.29
Price/Book--

Competitors

 Today’s
change
Today’s
% change
FATEFate Therapeutics In...-0.31-0.94%
----
ARVNArvinas Inc+1.78+3.19%
----
Data as of 2:40pm ET, 08/10/2022

Financials

Next reporting dateNovember 3, 2022
EPS forecast (this quarter)$4.80
Annual revenue (last year)$1.1B
Annual profit (last year)-$1.7B
Net profit margin-152.12%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Gaithersburg, Maryland

Forecasts